# Dose Escalated Radiotherapy for Rectal Cancers Using MR-guided Radiotherapy

> **NCT06854679** · NA · RECRUITING · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 13 (estimated)

## Conditions studied

- Rectal Adenocarcinoma

## Interventions

- **RADIATION:** Radiotherapy dose escalation

## Key facts

- **NCT ID:** NCT06854679
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-14
- **Primary completion:** 2027-01-13
- **Final completion:** 2029-01-13
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2025-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06854679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06854679, "Dose Escalated Radiotherapy for Rectal Cancers Using MR-guided Radiotherapy". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06854679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*